Literature DB >> 16691189

Antiproliferative effect of semaphorin 3F on human melanoma cell lines.

Isabelle Chabbert-de Ponnat, Valérie Buffard, Karen Leroy, Martine Bagot, Armand Bensussan, Pierre Wolkenstein, Anne Marie-Cardine.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2006        PMID： 16691189     DOI： 10.1038/sj.jid.5700382

Source DB:  PubMed          Journal:  J Invest Dermatol        ISSN： 0022-202X            Impact factor:   8.551


× No keyword cloud information.
  11 in total

1.  Semaphorin-3F functions as a tumor suppressor in colorectal cancer due to regulation by DNA methylation.

Authors:  Xuesong Gao; Chong Tang; Wen Shi; Shichun Feng; Weiyan Qin; Tian Jiang; Yongqiang Sun
Journal:  Int J Clin Exp Pathol       Date:  2015-10-01

2.  Integration of genotypic and phenotypic screening reveals molecular mediators of melanoma-stromal interaction.

Authors:  Megan J Stine; C Joanne Wang; Whei F Moriarty; Byungwoo Ryu; Raymond Cheong; William H Westra; Andre Levchenko; Rhoda M Alani
Journal:  Cancer Res       Date:  2011-02-15       Impact factor: 12.701

Review 3.  Role of Neuropilin-2-mediated signaling axis in cancer progression and therapy resistance.

Authors:  Ridwan Islam; Juhi Mishra; Sanika Bodas; Sreyashi Bhattacharya; Surinder K Batra; Samikshan Dutta; Kaustubh Datta
Journal:  Cancer Metastasis Rev       Date:  2022-07-01       Impact factor: 9.237

Review 4.  Semaphorin signals on the road to cancer invasion and metastasis.

Authors:  Sabrina Rizzolio; Luca Tamagnone
Journal:  Cell Adh Migr       Date:  2007-04-13       Impact factor: 3.405

5.  The role of semaphorins and their receptors in gliomas.

Authors:  Janice Wai Sze Law; Alan Yiu Wah Lee
Journal:  J Signal Transduct       Date:  2012-09-23

Review 6.  Neuropilin-1 as Therapeutic Target for Malignant Melanoma.

Authors:  Grazia Graziani; Pedro M Lacal
Journal:  Front Oncol       Date:  2015-06-03       Impact factor: 6.244

7.  Neuropilin-1 antagonism in human carcinoma cells inhibits migration and enhances chemosensitivity.

Authors:  H Jia; L Cheng; M Tickner; A Bagherzadeh; D Selwood; I Zachary
Journal:  Br J Cancer       Date:  2010-01-19       Impact factor: 7.640

8.  Neuropilins: a new target for cancer therapy.

Authors:  Camille Grandclement; Christophe Borg
Journal:  Cancers (Basel)       Date:  2011-04-08       Impact factor: 6.639

Review 9.  The emerging role of class-3 semaphorins and their neuropilin receptors in oncology.

Authors:  Patrick Nasarre; Robert M Gemmill; Harry A Drabkin
Journal:  Onco Targets Ther       Date:  2014-09-24       Impact factor: 4.147

10.  The axon guidance molecule semaphorin 3F is a negative regulator of tumor progression and proliferation in ileal neuroendocrine tumors.

Authors:  Julien Bollard; Patrick Massoma; Cécile Vercherat; Martine Blanc; Florian Lepinasse; Nicolas Gadot; Christophe Couderc; Gilles Poncet; Thomas Walter; Marie-Odile Joly; Valérie Hervieu; Jean-Yves Scoazec; Colette Roche
Journal:  Oncotarget       Date:  2015-11-03
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.